Literature DB >> 15385962

Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.

Diego Pasini1, Adrian P Bracken, Michael R Jensen, Eros Lazzerini Denchi, Kristian Helin.   

Abstract

SUZ12 is a recently identified Polycomb group (PcG) protein, which together with EZH2 and EED forms different Polycomb repressive complexes (PRC2/3). These complexes contain histone H3 lysine (K) 27/9 and histone H1 K26 methyltransferase activity specified by the EZH2 SET domain. Here we show that mice lacking Suz12, like Ezh2 and Eed mutant mice, are not viable and die during early postimplantation stages displaying severe developmental and proliferative defects. Consistent with this, we demonstrate that SUZ12 is required for proliferation of cells in tissue culture. Furthermore, we demonstrate that SUZ12 is essential for the activity and stability of the PRC2/3 complexes in mouse embryos, in tissue culture cells and in vitro. Strikingly, Suz12-deficient embryos show a specific loss of di- and trimethylated H3K27, demonstrating that Suz12 is indeed essential for EZH2 activity in vivo. In conclusion, our data demonstrate an essential role of SUZ12 in regulating the activity of the PRC2/3 complexes, which are required for regulating proliferation and embryogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385962      PMCID: PMC524339          DOI: 10.1038/sj.emboj.7600402

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

Authors:  H Müller; A P Bracken; R Vernell; M C Moroni; F Christians; E Grassilli; E Prosperini; E Vigo; J D Oliner; K Helin
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

2.  Use of chromatin immunoprecipitation to clone novel E2F target promoters.

Authors:  A S Weinmann; S M Bartley; T Zhang; M Q Zhang; P J Farnham
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

Review 3.  Translating the histone code.

Authors:  T Jenuwein; C D Allis
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

Review 4.  Polycomb repression: from cellular memory to cellular proliferation and cancer.

Authors:  Jacqueline J L Jacobs; Maarten van Lohuizen
Journal:  Biochim Biophys Acta       Date:  2002-06-21

5.  Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors.

Authors:  J I Koontz; A L Soreng; M Nucci; F C Kuo; P Pauwels; H van Den Berghe; P Dal Cin; J A Fletcher; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

6.  The polycomb-group gene Ezh2 is required for early mouse development.

Authors:  D O'Carroll; S Erhardt; M Pagani; S C Barton; M A Surani; T Jenuwein
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

8.  Stable suppression of tumorigenicity by virus-mediated RNA interference.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

9.  Su(z)12, a novel Drosophila Polycomb group gene that is conserved in vertebrates and plants.

Authors:  A Birve; A K Sengupta; D Beuchle; J Larsson; J A Kennison; J Müller
Journal:  Development       Date:  2001-09       Impact factor: 6.868

10.  The Polycomb-group gene eed is required for normal morphogenetic movements during gastrulation in the mouse embryo.

Authors:  C Faust; K A Lawson; N J Schork; B Thiel; T Magnuson
Journal:  Development       Date:  1998-11       Impact factor: 6.868

View more
  416 in total

Review 1.  Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2.

Authors:  Chiara Mozzetta; Julien Pontis; Slimane Ait-Si-Ali
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  Epigenetic modification of histone 3 lysine 27: mediator subunit MED25 is required for the dissociation of polycomb repressive complex 2 from the promoter of cytochrome P450 2C9.

Authors:  Neal A Englert; George Luo; Joyce A Goldstein; Sailesh Surapureddi
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

3.  PRC2 directly methylates GATA4 and represses its transcriptional activity.

Authors:  Aibin He; Xiaohua Shen; Qing Ma; Jingjing Cao; Alexander von Gise; Pingzhu Zhou; Gang Wang; Victor E Marquez; Stuart H Orkin; William T Pu
Journal:  Genes Dev       Date:  2012-01-01       Impact factor: 11.361

4.  Liganded thyroid hormone receptor induces nucleosome removal and histone modifications to activate transcription during larval intestinal cell death and adult stem cell development.

Authors:  Kazuo Matsuura; Kenta Fujimoto; Liezhen Fu; Yun-Bo Shi
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

Review 5.  Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer.

Authors:  Martin Sauvageau; Guy Sauvageau
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

6.  The JARID2-PRC2 duality.

Authors:  Hans-Martin Herz; Ali Shilatifard
Journal:  Genes Dev       Date:  2010-05       Impact factor: 11.361

7.  Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation.

Authors:  Nathan D Montgomery; Della Yee; Stephanie A Montgomery; Terry Magnuson
Journal:  J Mol Biol       Date:  2007-10-22       Impact factor: 5.469

8.  Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination.

Authors:  Katharina Steinmann; David N Cooper; Lan Kluwe; Nadia A Chuzhanova; Cornelia Senger; Eduard Serra; Conxi Lazaro; Montserrat Gilaberte; Katharina Wimmer; Viktor-Felix Mautner; Hildegard Kehrer-Sawatzki
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

Review 9.  EZH2: not EZHY (easy) to deal.

Authors:  Gauri Deb; Anup Kumar Singh; Sanjay Gupta
Journal:  Mol Cancer Res       Date:  2014-02-13       Impact factor: 5.852

10.  Cell-extrinsic hematopoietic impact of Ezh2 inactivation in fetal liver endothelial cells.

Authors:  Wen Hao Neo; Christopher A G Booth; Emanuele Azzoni; Lijun Chi; Paul Delgado-Olguín; Marella F T R de Bruijn; Sten Eirik W Jacobsen; Adam J Mead
Journal:  Blood       Date:  2018-03-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.